The role of PGC-1α in the development of insulin resistance in skeletal muscle - Revisited

Cellular Physiology and Biochemistry

Volumn 37, Issue 6, 2015, Pages 2288-2296

  Łukaszuk, Bartlomiej ^a   Kurek, Krzysztof ^a   Mikłosz, Agnieszka ^a   Zendzian Piotrowska, Małgorzata ^a   Chabowski, Adrian ^a  

^a MEDICAL UNIVERSITY OF BIALYSTOK   (Poland)

Author keywords

Bioactive lipids; Ceramide; Diacylglycerol; PGC 1 ; Skeletal muscle insulin resistance

Indexed keywords

PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA COACTIVATOR 1ALPHA; LIPID; PPARGC1A PROTEIN, HUMAN; TRANSCRIPTION FACTOR;

ANGIOGENESIS; DISEASE COURSE; ENERGY METABOLISM; EXERCISE; GENETIC TRANSCRIPTION; HUMAN; INSULIN RESISTANCE; LIPID METABOLISM; MITOCHONDRIAL RESPIRATION; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OBESITY; PEROXISOME; PHYSICAL ACTIVITY; PRIORITY JOURNAL; REVIEW; RISK FACTOR; SIGNAL TRANSDUCTION; SKELETAL MUSCLE; ANIMAL; CHEMISTRY; PATHOPHYSIOLOGY; PHYSIOLOGY;

ANIMALS; HUMANS; INSULIN RESISTANCE; LIPIDS; MUSCLE, SKELETAL; PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR GAMMA COACTIVATOR 1-ALPHA; SIGNAL TRANSDUCTION; TRANSCRIPTION FACTORS;

EID: 84949604935     PISSN: 10158987     EISSN: 14219778     Source Type: Journal    
DOI: 10.1159/000438584     Document Type: Review

References (52)

1. Media centre. Obesity and overweight. Fact sheet no311. http: //www.who.int/mediacentre/factsheets/ fs311/en/. World Health Organization, 2015
2. Smith U. Abdominal obesity: A marker of ectopic fat accumulation. J Clin Invest 2015; 125: 1790-1792
3. DeFronzo RA, Tripathy D. Skeletal muscle insulin resistance is the primary defect in type 2 diabetes. Diabetes Care 2009; 32: S157-163
4. Snel M, Jonker JT, Schoones J, Lamb H, de Roos A, Pijl H, Smit JW, Meinders AE, Jazet IM. Ectopic fat and insulin resistance: Pathophysiology and effect of diet and lifestyle interventions. Int J Endocrinol 2012; 2012: 983814
5. Zhang L, Keung W, Samokhvalov V, Wang W, Lopaschuk GD. Role of fatty acid uptake and fatty acid beta-oxidation in mediating insulin resistance in heart and skeletal muscle. Biochim Biophys Acta 2010; 1801: 1-22
6. Holloway GP. Mitochondrial function and dysfunction in exercise and insulin resistance. Appl Physiol Nutr Metab 2009; 34: 440-446
7. Larsen PJ, Tennagels N. On ceramides, other sphingolipids and impaired glucose homeostasis. Mol Metab 2014; 3: 252-260
8. Timmers S, Schrauwen P, de Vogel J. Muscular diacylglycerol metabolism and insulin resistance. Physiol Behav 2008; 94: 242-251
9. Sugden MC, Zariwala MG, Holness MJ. Ppars and the orchestration of metabolic fuel selection. Pharmacol Res 2009; 60: 141-150
10. Tyagi S, Gupta P, Saini AS, Kaushal C, Sharma S. The peroxisome proliferator-Activated receptor: A family of nuclear receptors role in various diseases. J Adv Pharm Technol Res 2011; 2: 236-240
11. Arany Z. Pgc-1 coactivators and skeletal muscle adaptations in health and disease. Curr Opin Genet Dev 2008; 18: 426-434
12. Rowe GC, Arany Z. Genetic models of pgc-1 and glucose metabolism and homeostasis. Rev Endocr Metab Disord 2014; 15: 21-29
13. Buler M, Aatsinki SM, Izzi V, Uusimaa J, Hakkola J. Sirt5 is under the control of pgc-1alpha and ampk and is involved in regulation of mitochondrial energy metabolism. FASEB J 2014; 28: 3225-3237
14. Sun L, Zang WJ, Wang H, Zhao M, Yu XJ, He X, Miao Y, Zhou J. Acetylcholine promotes ros detoxification against hypoxia/reoxygenation-induced oxidative stress through foxo3a/pgc-1alpha dependent superoxide dismutase. Cell Physiol Biochem 2014; 34: 1614-1625
15. Summermatter S, Shui G, Maag D, Santos G, Wenk MR, Handschin C. Pgc-1alpha improves glucose homeostasis in skeletal muscle in an activity-dependent manner. Diabetes 2013; 62: 85-95
16. Benton CR, Holloway GP, Han XX, Yoshida Y, Snook LA, Lally J, Glatz JF, Luiken JJ, Chabowski A, Bonen A. Increased levels of peroxisome proliferator-Activated receptor gamma, coactivator 1 alpha (pgc-1alpha) improve lipid utilisation, insulin signalling and glucose transport in skeletal muscle of lean and insulin-resistant obese zucker rats. Diabetologia 2010; 53: 2008-2019
17. Capurso C, Capurso A. From excess adiposity to insulin resistance: The role of free fatty acids. Vascul Pharmacol 2012; 57: 91-97
18. Bosma M, Kersten S, Hesselink MK, Schrauwen P. Re-evaluating lipotoxic triggers in skeletal muscle: Relating intramyocellular lipid metabolism to insulin sensitivity. Prog Lipid Res 2012; 51: 36-49
19. Harasim E, Stepek T, Konstantynowicz-Nowicka K, Baranowski M, Gorski J, Chabowski A. Myocardial lipid profiling during time course of high fat diet and its relationship to the expression of fatty acid transporters. Cell Physiol Biochem 2015; 37: 1147-1158
20. Lee S, Boesch C, Kuk JL, Arslanian S. Effects of an overnight intravenous lipid infusion on intramyocellular lipid content and insulin sensitivity in african-American versus caucasian adolescents. Metabolism 2013; 62: 417-423
21. van Loon LJ, Goodpaster BH. Increased intramuscular lipid storage in the insulin-resistant and endurance-Trained state. Pflugers Arch 2006; 451: 606-616
22. Fayyaz S, Japtok L, Kleuser B. Divergent role of sphingosine 1-phosphate on insulin resistance. Cell Physiol Biochem 2014; 34: 134-147
23. Miklosz A, Lukaszuk B, Baranowski M, Gorski J, Chabowski A. Effects of inhibition of serine palmitoyltransferase (spt) and sphingosine kinase 1 (sphk1) on palmitate induced insulin resistance in l6 myotubes. PLoS One 2013; 8: e85547
24. Itani SI, Ruderman NB, Schmieder F, Boden G. Lipid-induced insulin resistance in human muscle is associated with changes in diacylglycerol, protein kinase c, and ikappab-Alpha. Diabetes 2002; 51: 2005-2011
25. Turner N, Cooney GJ, Kraegen EW, Bruce CR. Fatty acid metabolism, energy expenditure and insulin resistance in muscle. J Endocrinol 2014; 220: T61-79
26. Kurek K, Miklosz A, Lukaszuk B, Chabowski A, Gorski J, Zendzian-Piotrowska M. Inhibition of ceramide de novo synthesis ameliorates diet induced skeletal muscles insulin resistance. J Diabetes Res 2015; 2015: 154762
27. Selathurai A, Kowalski GM, Burch ML, Sepulveda P, Risis S, Lee-Young RS, Lamon S, Meikle PJ, Genders AJ, McGee SL, Watt MJ, Russell AP, Frank M, Jackowski S, Febbraio MA, Bruce CR. The cdp-ethanolamine pathway regulates skeletal muscle diacylglycerol content and mitochondrial biogenesis without altering insulin sensitivity. Cell Metab 2015; 21: 718-730
28. Chabowski A, Zendzian-Piotrowska M, Nawrocki A, Gorski J. Not only accumulation, but also saturation status of intramuscular lipids is significantly affected by ppargamma activation. Acta Physiol (Oxf) 2012; 205: 145-158
29. Lukaszuk B, Miklosz A, Chabowski A, Gorski J. Modest decrease in pgc1alpha results in tag accumulation but not in insulin resistance in l6 myotubes. Cell Physiol Biochem 2015; 35: 1609-1622
30. Lee YS, Li P, Huh JY, Hwang IJ, Lu M, Kim JI, Ham M, Talukdar S, Chen A, Lu WJ, Bandyopadhyay GK, Schwendener R, Olefsky J, Kim JB. Inflammation is necessary for long-Term but not short-Term high-fat diet-induced insulin resistance. Diabetes 2011; 60: 2474-2483
31. Correia JC, Ferreira DM, Ruas JL. Intercellular: Local and systemic actions of skeletal muscle pgc-1s. Trends Endocrinol Metab 2015; 26: 305-314
32. Smyth S, Heron A. Diabetes and obesity: The twin epidemics. Nat Med 2006; 12: 75-80
33. Oberkofler H, Linnemayr V, Weitgasser R, Klein K, Xie M, Iglseder B, Krempler F, Paulweber B, Patsch W. Complex haplotypes of the pgc-1alpha gene are associated with carbohydrate metabolism and type 2 diabetes. Diabetes 2004; 53: 1385-1393
34. Hara K, Tobe K, Okada T, Kadowaki H, Akanuma Y, Ito C, Kimura S, Kadowaki T. A genetic variation in the pgc-1 gene could confer insulin resistance and susceptibility to type ii diabetes. Diabetologia 2002; 45: 740-743
35. Mootha VK, Lindgren CM, Eriksson KF, Subramanian A, Sihag S, Lehar J, Puigserver P, Carlsson E, Ridderstrale M, Laurila E, Houstis N, Daly MJ, Patterson N, Mesirov JP, Golub TR, Tamayo P, Spiegelman B, Lander ES, Hirschhorn JN, Altshuler D, Groop LC. Pgc-1alpha-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes. Nat Genet 2003; 34: 267-273
36. Patti ME, Butte AJ, Crunkhorn S, Cusi K, Berria R, Kashyap S, Miyazaki Y, Kohane I, Costello M, Saccone R, Landaker EJ, Goldfine AB, Mun E, DeFronzo R, Finlayson J, Kahn CR, Mandarino LJ. Coordinated reduction of genes of oxidative metabolism in humans with insulin resistance and diabetes: Potential role of pgc1 and nrf1. Proc Natl Acad Sci USA 2003; 100: 8466-8471
37. Naples SP, Borengasser SJ, Rector RS, Uptergrove GM, Morris EM, Mikus CR, Koch LG, Britton SL, Ibdah JA, Thyfault JP. Skeletal muscle mitochondrial and metabolic responses to a high-fat diet in female rats bred for high and low aerobic capacity. Appl Physiol Nutr Metab 2010; 35: 151-162
38. Lin J, Wu PH, Tarr PT, Lindenberg KS, St-Pierre J, Zhang CY, Mootha VK, Jager S, Vianna CR, Reznick RM, Cui L, Manieri M, Donovan MX, Wu Z, Cooper MP, Fan MC, Rohas LM, Zavacki AM, Cinti S, Shulman GI, Lowell BB, Krainc D, Spiegelman BM. Defects in adaptive energy metabolism with cns-linked hyperactivity in pgc-1alpha null mice. Cell 2004; 119: 121-135
39. Summermatter S, Baum O, Santos G, Hoppeler H, Handschin C. Peroxisome proliferator-Activated receptor {gamma} coactivator 1{alpha} (pgc-1{alpha}) promotes skeletal muscle lipid refueling in vivo by activating de novo lipogenesis and the pentose phosphate pathway. J Biol Chem 2010; 285: 32793-32800
40. Choi CS, Befroy DE, Codella R, Kim S, Reznick RM, Hwang YJ, Liu ZX, Lee HY, Distefano A, Samuel VT, Zhang D, Cline GW, Handschin C, Lin J, Petersen KF, Spiegelman BM, Shulman GI. Paradoxical effects of increased expression of pgc-1alpha on muscle mitochondrial function and insulin-stimulated muscle glucose metabolism. Proc Natl Acad Sci USA 2008; 105: 19926-19931
41. Calvo JA, Daniels TG, Wang X, Paul A, Lin J, Spiegelman BM, Stevenson SC, Rangwala SM. Muscle-specific expression of ppargamma coactivator-1alpha improves exercise performance and increases peak oxygen uptake. J Appl Physiol (1985) 2008; 104: 1304-1312
42. Espinoza DO, Boros LG, Crunkhorn S, Gami H, Patti ME. Dual modulation of both lipid oxidation and synthesis by peroxisome proliferator-Activated receptor-gamma coactivator-1alpha and-1beta in cultured myotubes. FASEB J 2010; 24: 1003-1014
43. Hoeks J, Arany Z, Phielix E, Moonen-Kornips E, Hesselink MK, Schrauwen P. Enhanced lipid-but not carbohydrate-supported mitochondrial respiration in skeletal muscle of pgc-1alpha overexpressing mice. J Cell Physiol 2012; 227: 1026-1033
44. Kiens B. Skeletal muscle lipid metabolism in exercise and insulin resistance. Physiol Rev 2006; 86: 205-243
45. Altshuler B. Modeling of dose-response relationships. Environ Health Perspect 1981; 42: 23-27
46. Vandenberg LN, Colborn T, Hayes TB, Heindel JJ, Jacobs DR, Jr, Lee DH, Shioda T, Soto AM, vom Saal FS, Welshons WV, Zoeller RT, Myers JP. Hormones and endocrine-disrupting chemicals: Low-dose effects and nonmonotonic dose responses. Endocr Rev 2012; 33: 378-455
47. Los M, Maddika S, Erb B, Schulze-Osthoff K. Switching akt: From survival signaling to deadly response. Bioessays 2009; 31: 492-495
48. Benton CR, Wright DC, Bonen A. Pgc-1alpha-mediated regulation of gene expression and metabolism: Implications for nutrition and exercise prescriptions. Appl Physiol Nutr Metab 2008; 33: 843-862
49. Irrcher I, Adhihetty PJ, Sheehan T, Joseph AM, Hood DA. Ppargamma coactivator-1alpha expression during thyroid hormone-And contractile activity-induced mitochondrial adaptations. Am J Physiol Cell Physiol 2003; 284: C1669-1677
50. Lai L, Leone TC, Zechner C, Schaeffer PJ, Kelly SM, Flanagan DP, Medeiros DM, Kovacs A, Kelly DP. Transcriptional coactivators pgc-1alpha and pgc-lbeta control overlapping programs required for perinatal maturation of the heart. Genes Dev 2008; 22: 1948-1961
51. Puigserver P, Wu Z, Park CW, Graves R, Wright M, Spiegelman BM. A cold-inducible coactivator of nuclear receptors linked to adaptive thermogenesis. Cell 1998; 92: 829-839
52. Chan MC, Arany Z. The many roles of pgc-1alpha in muscle-recent developments. Metabolism 2014; 63: 441-451